Changes in markers of ovarian reserve and endocrine function in young women with breast cancer undergoing adjuvant chemotherapy

Gonadotropin-releasing hormone analogues

Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma

✍ Francesco Recchia; Gaetano Saggio; Giovanna Amiconi; Anna Di Blasio; Alisia Cest 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 1 views

## Abstract ## BACKGROUND The objective of the current study was a retrospective evaluation of 100 consecutive premenopausal women with high‐risk, early breast carcinoma who received a gonadotropin‐releasing hormone (Gn‐RH) analogue as ovarian protection during adjuvant chemotherapy. ## METHODS